Privigen Liquid
Product Images NDC 44206-436
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Privigen (NDC 44206-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Csl Behring Ag, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (50 mL Vial Carton)
Principal Display Panel (100 mL Vial Carton)
This is a package of 10% Liquid Preparation Single-dose vial, containing 10g immunoglobulin (human) in 100 mL solution. It is used for Intravenous Administration only. The package contains complete instructions for use. The patient and physician should discuss the risks and benefits of this product. The storage temperature should be at room temperature (up to 25°C [77°F]). If the solution is cloudy or contains particles, it should not be used, and partial contents should be discarded after use. The package includes a Patient Notification System. The product is manufactured by CSLBehring AG in Bem, Switzerland, and distributed by CSLBehring LLC. Patent numbers and licensing information are provided.*
Principal Display Panel (200 mL Vial Carton)
This is a package insert for Privigen, which is a 10% liquid immune globulin preparation for intravenous administration. It contains immunoglobulin, a prescription medication used to strengthen the immune system of individuals with certain conditions. The package provides information about dosage, storage, and manufacturer details.*
Principal Display Panel (400 mL Vial Carton)
This is a description of a medication called Privigen. It is an immune globulin (human) intravenous liquid that comes in a single-dose vial. It contains 40g immunoglobulin (human) in 400mL solution, and is manufactured by CSL Behring AG, Switzerland. The medication is for intravenous use only and is stable at room temperature. Complete directions for use are included in the package insert. The patient and physician should discuss potential risks and benefits of this product before use. The package also includes a patent number and a phone number to enrol in a confidential patient notification system.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.